CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,772,310 | +366.5% | 117,400 | +769.6% | 0.69% | +3181.0% |
| Q4 2021 | $1,023,000 | -82.3% | 13,500 | -73.8% | 0.02% | -88.0% |
| Q3 2021 | $5,764,000 | -42.5% | 51,500 | -16.8% | 0.18% | -50.8% |
| Q2 2021 | $10,021,000 | -73.5% | 61,900 | -80.1% | 0.36% | -62.4% |
| Q1 2021 | $37,883,000 | +302.3% | 310,900 | +405.5% | 0.95% | +428.5% |
| Q4 2020 | $9,416,000 | +34.9% | 61,500 | -35.3% | 0.18% | -62.9% |
| Q2 2020 | $6,981,000 | – | 95,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |